Journal of Clinical Epidemiology
Volume 53, Issue 9 , Pages 908-919 , September 2000

Measuring quality of sedation in adult mechanically ventilated critically ill patients: the Vancouver Interaction and Calmness Scale

  • Jane de Lemos

      Affiliations

    • Clinical Service Unit: Pharmaceutical Sciences, Vancouver General Hospital and Faculty of Pharmaceutical Sciences, University of British Columbia, 855 W 12th Avenue, Vancouver, British Columbia, Canada V5Z 1M9
    • Corresponding Author InformationCorresponding author. Tel: 604 875 4077; fax: 604 875 5267.(J. de Lemos)
    • ,
  • Martin Tweeddale

      Affiliations

    • Program of Critical Care Medicine, University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • Dean Chittock

      Affiliations

    • Program of Critical Care Medicine, University of British Columbia, Vancouver, British Columbia, Canada
    • ,
  • for the Sedation Focus Group

      Affiliations

Received 26 May 1999 ,Revised 7 December 1999 ,Accepted 21 January 2000.

References 

  1. Hansen-Flaschen J, Cowen J, Polomano RC. Beyond the Ramsay scale (need for a validated measure of sedating drug efficacy in the intensive care unit). Crit Care Med. 1994;22:732–733
  2. Stewart AL, Hays RD, Ware JE. Methods of constructing health measures. In:  Stewart AL,  Ware JE editor. Measuring Functioning and Well-Being (the medical outcomes study approach). Durham: Duke University Press;; 1992;
  3. Nunally J. Psychometric Theory. 2nd ed. New York: McGraw Hill; 1978;
  4. Fayers PM, Machin D. Factor analysis. In:  Staquet MJ,  Hays RD,  Fayers PM editor. Quality of Life Assessment in Clinical Trials (Methods and Practice). Oxford/New York: Oxford University Press; 1998;p. 191–223
  5. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297–334
  6. Shrout PE, Fleiss JL. Intraclass correlations (uses in assessing rater reliability). Psychol Bull. 1979;86:420–428
  7. Jaeshke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimally clinically important difference. Controlled Clin Trials. 1989;10:407–415
  8. Guyatt GH, Devo RA, Charlson M, Levine MN, Mitchell A. Responsiveness and validity in health status measurement (a clarification). J Clin Epidemiol. 1989;5:403–408
  9. Katz JN, Larson MG, Phillips CB, Fossel AH, Liang MH. Comparative measurement sensitivity of short and longer health status instruments. Med Care. 1992;20:917–925
  10. Guyatt G, Walter S, Norman G. Measuring change over time (assessing the usefulness of evaluative instruments). J Chron Dis. 1987;40:171–178
  11. Streiner DL, Norman GR. Health Measurement Scales. A Practical Guide to Their Development and Use. 2nd ed. Oxford: Oxford University Press; 1995;
  12. Ramsay MAE, Savage TM, Simpson BJR, et al.  Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974;2:656–659
  13. Aitkenhead AR, Willatts SM, Park GR, Collins CH, Ledingham IM, Pepperman ML, et al.  Comparison of propofol and midazolam for sedation in critically ill patients. Lancer. 1989;2:704–709
  14. O'Sullivan G, Park GR. The assessment of sedation. J Clin Intensive Care. 1990;1:116–122
  15. Yate PM, Thomas D, Short SM, Sebel PS, Morton J. Comparison of infusions of alfentanil or pethidine for sedation of ventilated patients on the ITU. Br J Anaesth. 1986;58:1091–1099
  16. Cohen AT, Kelly DR. Assessment of alfentanil by intravenous infusion as long term sedation in intensive care. Anaesthesia. 1987;42:545–548
  17. Revicki DA, Kline Leidy N. Questionnaire scaling (models and issues). In:  Staquet MJ,  Hays RD,  Fayers PM editor. Quality of Life Assessment in Clinical Trials (Methods and Practice). Oxford/New York: Oxford University Press; 1998;p. 157–168
  18. Cook S, Palma O. Propofol as a sole agent for prolonged infusion in intensive care. J Drug Dev. 1989;4(suppl. 2):65–67
  19. Carrasco G, Molina R, Costa J, Soler JM, Paniagua J, Cabre LI. Usefulness of sedation scales in ICU. A comparative randomized study in patients sedated with propofol, midazolam or opiates plus benzodiazepines. Intensive Care Med. 1992;18:P158;[abstract]
  20. Bartko JJ. Measurement and reliability (statistical thinking considerations). Schizophr Bull. 1991;17:483–489
  21. McDowell I, Newell C. Measuring Health. A Guide to Rating Scales and Questionnaires. 2nd ed. Oxford: Oxford University Press; 1996;pp. 10–46.
  22. Laing ASM. The applicability of a new sedation scale for intensive care. Intensive Crit Care Nurs. 1992;8:149–152
  23. Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB, et al.  Validity and reliability of the observer's assessment of alertness/sedation scale (study with intravenous midazolam). J Clin Psychopharmacol. 1990;10:244–251
  24. Chernik DA, Ticker M, Gigli B, Kisook Y, Kala P, Laine H, et al.  Validity and reliability of the neurobehavioral assessment scale. J Clin Psychopharmacol. 1992;12:43–48
  25. Macnab AJ, Levine M, Click N, Susak L, Baker-Brown G. A research tool for measurement of recovery from sedation (the Vancouver sedative recovery scale). J Pediatr Surg. 1991;26:1263–1267
  26. Ambuel B, Hamlett KW, Marx CM, Blumer JL. Assessing distress in pediatric intensive care environments—the COMFORT scale. J Pediatr Psychol. 1992;17:95–109
  27. White PF, Boyle W. Relationship between hemodynamic and electroencephalographic changes during general anaesthesia. Anaesth Analg. 1989;68:177–181
  28. Sinclair ME, Suter PM. Detection of overdosage of sedation in a patient with renal failure by the absence of lower oesophageal motility. Intensive Care Med. 1988;14:69–71
  29. Haberthur C, Lehmann F, Ritz R. Assessment of sedation using objective parameters. Intensive Care Med. 1996;22:1385–1390
  30. Liu J, Singh H, White PF. Electroencephalogram bispectral analysis predicts the depth of midazolam-induced sedation. Anesthesiology. 1996;84:64–69
  31. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures. Controlled Clin Trials. 1991;12:142S–158S
  32. Marx RG, Bombardier C, Hogg-Johnson S, Wright JG. Clinimetric and psychometric strategies for development of a health measurement scale. J Clin Epidemiol. 1999;52:105–111
  33. Kirshner B, Guyatt G. A methodological framework for assessing health indices. J Chron Dis. 1985;38:27–36
  34. Guyatt GH, Townsend M, Keller JL, Singer J. Should study subjects see their previous responses (data from a randomized controlled trial). J Clin Epidemiol. 1989;4:913–920
  35. Shults J, Chaganty NR. Analysis of serially correlated data using quasi-least squares. Biometrics. 1998;54:1622–1630
  36. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13–22

PII: S0895-4356(00)00208-0

Journal of Clinical Epidemiology
Volume 53, Issue 9 , Pages 908-919 , September 2000

Article Tools